PERIPHERAL ARTERY DISEASE (PAD)
Clinical trials for PERIPHERAL ARTERY DISEASE (PAD) explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL ARTERY DISEASE (PAD) trials appear
Sign up with your email to follow new studies for PERIPHERAL ARTERY DISEASE (PAD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sound waves vs. hardened arteries: new device tested for leg pain
Disease control Not yet recruitingThis study tests a new device that uses sound waves to break up hard calcium deposits in the leg arteries of people with peripheral artery disease (PAD). About 110 adults will receive a minimally invasive procedure and be followed for 6 months. The goal is to see if the device sa…
Matched conditions: PERIPHERAL ARTERY DISEASE (PAD)
Phase: NA • Sponsor: FastWave Medical • Aim: Disease control
Last updated May 17, 2026 02:42 UTC
-
New hope for PAD patients: experimental drugs aim to stop deadly clots after leg surgery
Disease control Not yet recruitingThis study tests two experimental drugs, REGN7508 and REGN9933, to see if they can prevent life-threatening blood clots in people with peripheral artery disease (PAD) who recently had leg surgery to improve blood flow. About 7,050 participants will be randomly assigned to receive…
Matched conditions: PERIPHERAL ARTERY DISEASE (PAD)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 02:38 UTC
-
Chocolate balloon may reduce stenting in leg artery disease
Disease control Not yet recruitingThis study compares a special balloon (Chocolate PTA) to a standard balloon for preparing narrowed or blocked leg arteries before using a drug-coated balloon. About 242 adults with peripheral artery disease will be randomly assigned to one of the two preparation methods. The goal…
Matched conditions: PERIPHERAL ARTERY DISEASE (PAD)
Phase: NA • Sponsor: Felice Pecoraro • Aim: Disease control
Last updated May 14, 2026 12:06 UTC